{
    "2020-05-14": [
        [
            {
                "time": "2021-03-15",
                "original_text": "The Zacks Analyst Blog Highlights: LLY, AZN, PFE, SNY and BMY",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "LLY",
                        "AZN",
                        "PFE",
                        "SNY",
                        "BMY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Coronavirus Vaccine Progress Accelerates",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Vaccine",
                        "Progress",
                        "Accelerates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Three Dividend Growth Stocks We Recently Purchased for Our Portfolio",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Growth",
                        "Stocks",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Relaxing the Lockdown: Move Slowly, Stay Nimble",
                "features": {
                    "keywords": [
                        "Relaxing",
                        "Lockdown",
                        "Move Slowly",
                        "Stay Nimble"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy",
                        "policy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Positive",
                        "Top-Line",
                        "Results",
                        "Phase 3",
                        "Lot Consistency",
                        "Study",
                        "20-Valent",
                        "Pneumococcal",
                        "Conjugate",
                        "Vaccine"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}